Scholz I, Montoya C, Vela E. Examination of vesicular stomatitis virus-induced morphology changes in individual Vero cells by QMod microscopy. BioTechniques 68: 00-00 (June 2020) 10.2144/btn-2019-0137
Scholz I, Montoya C, Vela E. Examination of vesicular stomatitis virus-induced morphology changes in individual Vero cells by QMod microscopy. BioTechniques 68: 00-00 (June 2020) 10.2144/btn-2019-0137
COVID-19 LetterPlease read the letter from our CEO regarding the precautionary measures we are taking at Ology Bioservices.
July 17, 2020
Dear Friends of Ology Bioservices:
These are unprecedented times as we respond to avoid the spread of COVID-19, a novel coronavirus that has challenged our routine life. First and foremost, all of us at Ology Bioservices Inc. hope you and your family members are well, healthy, and safe from harm’s way.
Below are some of the steps we are taking to protect our staff, our operations, and importantly all ongoing projects at Ology Bioservices during this time. Our goal is to be prepared to continue serving our clients during this time of uncertainty. In order to protect our employees and facility, and to keep projects moving forward, we have implemented the following activities:
There will be no disruption in communicating with Ology Bioservices personnel, and our offices will remain open. However, the limited number of personnel physically at our locations will mainly consist of those involved in supporting the process development and manufacturing of our customer’s biological products. Be assured that you will be able to reach all employees through their direct phone lines and email regardless of their location during this crisis.
The entire leadership team at Ology Bioservices remain committed to the health and safety of our employees, as well as committed to the customers we serve. This nation has a history of strength and resilience, and I am certain that together we will successfully navigate these challenges.
Sincerely,
Peter H. Khoury
President & CEO